Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -7104.24% is 5499% below its 5-year average of -126.89%, near the low end of its 5-year range (-7104.24%–-60.24%).
2618.91% below its 12-month average of -261.29%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -90.35%.
RETURN ON EQUITY (ROE)
-7104.24%
RETURN ON EQUITY (ROE) AVG TTM
-261.29%
RETURN ON EQUITY (ROE) AVG 3Y
-162.24%
RETURN ON EQUITY (ROE) AVG 5Y
-126.89%
RETURN ON EQUITY (ROE) AVG 10Y
-111.22%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-2618.91%
CURRENT VS 3Y AVG
-4278.82%
CURRENT VS 5Y AVG
-5498.70%
CURRENT VS 10Y AVG
-6287.47%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.44%
median of 550 covered companies
CURRENT VS SECTOR MEDIAN
-17915.06%
vs the sector median at left
Cue Biopharma, Inc.
Market Cap
$173.89M
Return on Equity (ROE)
-7104.24%
TTM Avg
-261.29%
3Y Avg
-162.24%
5Y Avg
-126.89%
Market Cap
$172.77M
Return on Equity (ROE)
-56.61%
TTM Avg
-75.88%
3Y Avg
-88.15%
5Y Avg
-30.55%
Market Cap
$172.18M
Return on Equity (ROE)
-116.42%
TTM Avg
-18.43%
3Y Avg
-136.68%
5Y Avg
-137.61%
Market Cap
$172.07M
Return on Equity (ROE)
-47.36%
TTM Avg
-30.00%
3Y Avg
-33.39%
5Y Avg
-32.72%
Market Cap
$177.78M
Return on Equity (ROE)
-44.23%
TTM Avg
-36.61%
3Y Avg
-30.86%
5Y Avg
-42.66%
Market Cap
$169.41M
Return on Equity (ROE)
3.51%
TTM Avg
-6.60%
3Y Avg
-9.04%
5Y Avg
-6.71%
Market Cap
$179.09M
Return on Equity (ROE)
-19.01%
TTM Avg
-54.50%
3Y Avg
-75.60%
5Y Avg
-59.28%
Market Cap
$168.56M
Return on Equity (ROE)
-31.32%
TTM Avg
4.38%
3Y Avg
4.09%
5Y Avg
11.26%
Market Cap
$180.85M
Return on Equity (ROE)
-21.57%
TTM Avg
-470.91%
3Y Avg
-299.18%
5Y Avg
-180.76%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $173.89M | -7104.24% | -261.29% | -162.24% | -126.89% |
| MediWound Ltd. (MDWD)vs › | $172.77M | -56.61% | -75.88% | -88.15% | -30.55% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.18M | -116.42% | -18.43% | -136.68% | -137.61% |
| Nkarta, Inc. (NKTX)vs › | $172.07M | -47.36% | -30.00% | -33.39% | -32.72% |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.78M | -44.23% | -36.61% | -30.86% | -42.66% |
| OptimizeRx Corp. (OPRX)vs › | $169.41M | 3.51% | -6.60% | -9.04% | -6.71% |
| Journey Medical Corporation (DERM)vs › | $179.09M | -19.01% | -54.50% | -75.60% | -59.28% |
| Organogenesis Holdings Inc. (ORGO)vs › | $168.56M | -31.32% | 4.38% | 4.09% | 11.26% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.85M | -21.57% | -470.91% | -299.18% | -180.76% |
| Coherus Oncology, Inc. (CHRS)vs › | $165.32M | -215.26% | -150.35% | 8.65% | -35.35% |
ROE
-7104.2%
ROA
-534.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -90.35% |
| 2025-12-31 | -100.64% |
| 2025-09-30 | -284.49% |
| 2025-06-30 | -214.19% |
| 2025-03-31 | -616.78% |
| 2024-12-31 | -232.44% |
| 2024-09-30 | -175.87% |
| 2024-06-30 | -217.17% |
| 2024-03-31 | -166.36% |
| 2023-12-31 | -136.80% |
| 2023-09-30 | -121.62% |
| 2023-06-30 | -112.69% |
| 2023-03-31 | -94.27% |
| 2022-12-31 | -80.71% |
| 2022-09-30 | -92.20% |
| 2022-06-30 | -81.73% |
| 2022-03-31 | -70.99% |
| 2021-12-31 | -67.43% |
| 2021-09-30 | -73.80% |
| 2021-06-30 | -60.24% |
| 2021-03-31 | -63.83% |
| 2020-12-31 | -56.75% |
| 2020-09-30 | -48.66% |
| 2020-06-30 | -49.35% |
| 2020-03-31 | -84.55% |
| 2019-12-31 | -67.23% |
| 2019-09-30 | -145.81% |
| 2019-06-30 | -221.73% |
| 2019-03-31 | -172.80% |
| 2018-12-31 | -114.81% |
| 2018-09-30 | -95.98% |
| 2018-06-30 | -61.53% |
| 2018-03-31 | -49.61% |
| 2017-12-31 | -37.71% |
| 2017-09-30 | -356.96% |
| 2017-06-30 | -145.81% |
| 2017-03-31 | -63.35% |
| 2016-12-31 | -50.47% |
